| Systemic Sclerosis and Related Diseases | Lifetime | 2 | FR 1 | 99.85 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 14 | FR 2 | 99.55 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 48 | FR 7 | 99.53 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 66 | FR 7 | 99.45 |
| Systemic Lupus Erythematosus Research | Lifetime | 149 | FR 9 | 99.40 |
| Eosinophilic Disorders and Syndromes | Lifetime | 77 | FR 6 | 99.18 |
| Vasculitis and related conditions | Lifetime | 83 | FR 9 | 98.88 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 94 | FR 5 | 98.52 |
| Skin Diseases and Diabetes | Lifetime | 39 | FR 3 | 98.60 |
| Inflammasome and immune disorders | Lifetime | 203 | FR 15 | 97.81 |
| Mast cells and histamine | Lifetime | 188 | FR 11 | 97.58 |
| Autoimmune Bullous Skin Diseases | Lifetime | 289 | FR 20 | 97.84 |
| Dermatologic Treatments and Research | Lifetime | 230 | FR 8 | 97.57 |
| Vascular Anomalies and Treatments | Lifetime | 95 | FR 17 | 97.49 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 758 | FR 54 | 97.12 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 236 | FR 17 | 96.55 |
| Salivary Gland Disorders and Functions | Lifetime | 338 | FR 16 | 96.33 |
| Dermatological and Skeletal Disorders | Lifetime | 217 | FR 14 | 95.67 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 160 | FR 19 | 95.49 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 898 | FR 33 | 95.12 |
| Urticaria and Related Conditions | Lifetime | 635 | FR 38 | 95.18 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 953 | FR 55 | 94.59 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 940 | FR 47 | 94.12 |
| Connective Tissue Growth Factor Research | Lifetime | 146 | FR 7 | 92.69 |
| Peripheral Neuropathies and Disorders | Lifetime | 872 | FR 67 | 94.27 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 172 | FR 6 | 92.52 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 387 | FR 12 | 89.76 |
| Aortic Thrombus and Embolism | Lifetime | 771 | FR 52 | 64.70 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 28 | FR 5 | 98.52 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 71 | FR 5 | 96.12 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 383 | FR 21 | 93.53 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 505 | FR 28 | 93.24 |
| Salivary Gland Disorders and Functions | 2021-2025 | 260 | FR 16 | 86.10 |
| Pulmonary Hypertension Research and Treatments | 2021-2025 | 852 | FR 38 | 86.05 |
| Vasculitis and related conditions | 2021-2025 | 626 | FR 61 | 82.60 |
| Salivary Gland Tumors Diagnosis and Treatment | 2021-2025 | 624 | FR 26 | 79.66 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 686 | FR 42 | 76.91 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 288 | FR 57 | 76.17 |
| Skin Diseases and Diabetes | 2021-2025 | 178 | FR 8 | 71.09 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 820 | FR 44 | 72.71 |
| Connective Tissue Growth Factor Research | 2021-2025 | 76 | FR 3 | 66.79 |
| Mast cells and histamine | 2021-2025 | 802 | FR 53 | 64.80 |
| Dermatological and COVID-19 studies | 2021-2025 | 568 | FR 21 | 57.98 |
| Vascular Anomalies and Treatments | 2021-2025 | 602 | FR 91 | 56.31 |
| Intramuscular injections and effects | 2021-2025 | 337 | FR 16 | 39.83 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 966 | FR 34 | 36.72 |
